Longitudinal changes in estimated and measured GFR in type 1 diabetes

Ian H. De Boer, Wanjie Sun, Patricia A. Cleary, John M. Lachin, Mark E. Molitch, Bernard Zinman, Michael W Steffes

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Estimation of GFR from serum concentrations of creatinine and cystatin C has been refined using crosssectional data fromlarge numbers of people.However, the ability of the improved estimating equations to identify changes in GFR within individuals over time has not been rigorously evaluated, particularly within the normal range of GFR. In cross-sectional and longitudinal analyses of 1441 participants in the Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) study with type 1 diabetes, we compared GFR estimated from creatinine (eGFRCr), cystatin C (eGFRCys), or both (eGFRCr+Cys) with iothalamate GFR (iGFR), including changes in each over time. Mean (SD) iGFR was 122.7 (21.0)ml/min per 1.73m2. In cross-sectional analyses, eGFRCr+Cys estimated iGFRwith the highest correlation (r=0.48 versus 0.39-0.42), precision, and accuracy. In longitudinal analyses, change in eGFRCr+Cys best estimated change in iGFR; however, differences between estimates were small, and no estimate accurately classified change in iGFR.Over a median 23 years of follow-up,mean rate of change in eGFR was similar across estimates of eGFRCr, eGFRCys, and eGFRCr+Cys (21.37, 21.11, and 21.29 ml/min per 1.73 m2 per year, respectively). Associations of BP and hemoglobin A1c with change in eGFR were strongest for eGFRCys and eGFRCr+Cys. Together, these results suggest that the addition of cystatin C to creatinine to estimate GFRmay improve identification of the causes and consequences of GFR loss in type 1 diabetes, but may not meaningfully improve the tracking of GFR in clinical care.

Original languageEnglish (US)
Pages (from-to)810-818
Number of pages9
JournalJournal of the American Society of Nephrology
Volume25
Issue number4
DOIs
StatePublished - Apr 1 2014

Fingerprint

Cystatin C
Iothalamic Acid
Type 1 Diabetes Mellitus
Creatinine
Diabetes Complications
Cross-Sectional Studies
Reference Values
Hemoglobins
Epidemiology
Serum

Cite this

Longitudinal changes in estimated and measured GFR in type 1 diabetes. / De Boer, Ian H.; Sun, Wanjie; Cleary, Patricia A.; Lachin, John M.; Molitch, Mark E.; Zinman, Bernard; Steffes, Michael W.

In: Journal of the American Society of Nephrology, Vol. 25, No. 4, 01.04.2014, p. 810-818.

Research output: Contribution to journalArticle

De Boer, Ian H. ; Sun, Wanjie ; Cleary, Patricia A. ; Lachin, John M. ; Molitch, Mark E. ; Zinman, Bernard ; Steffes, Michael W. / Longitudinal changes in estimated and measured GFR in type 1 diabetes. In: Journal of the American Society of Nephrology. 2014 ; Vol. 25, No. 4. pp. 810-818.
@article{d51d8c98d7fc477a910ec6cde9df74b1,
title = "Longitudinal changes in estimated and measured GFR in type 1 diabetes",
abstract = "Estimation of GFR from serum concentrations of creatinine and cystatin C has been refined using crosssectional data fromlarge numbers of people.However, the ability of the improved estimating equations to identify changes in GFR within individuals over time has not been rigorously evaluated, particularly within the normal range of GFR. In cross-sectional and longitudinal analyses of 1441 participants in the Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) study with type 1 diabetes, we compared GFR estimated from creatinine (eGFRCr), cystatin C (eGFRCys), or both (eGFRCr+Cys) with iothalamate GFR (iGFR), including changes in each over time. Mean (SD) iGFR was 122.7 (21.0)ml/min per 1.73m2. In cross-sectional analyses, eGFRCr+Cys estimated iGFRwith the highest correlation (r=0.48 versus 0.39-0.42), precision, and accuracy. In longitudinal analyses, change in eGFRCr+Cys best estimated change in iGFR; however, differences between estimates were small, and no estimate accurately classified change in iGFR.Over a median 23 years of follow-up,mean rate of change in eGFR was similar across estimates of eGFRCr, eGFRCys, and eGFRCr+Cys (21.37, 21.11, and 21.29 ml/min per 1.73 m2 per year, respectively). Associations of BP and hemoglobin A1c with change in eGFR were strongest for eGFRCys and eGFRCr+Cys. Together, these results suggest that the addition of cystatin C to creatinine to estimate GFRmay improve identification of the causes and consequences of GFR loss in type 1 diabetes, but may not meaningfully improve the tracking of GFR in clinical care.",
author = "{De Boer}, {Ian H.} and Wanjie Sun and Cleary, {Patricia A.} and Lachin, {John M.} and Molitch, {Mark E.} and Bernard Zinman and Steffes, {Michael W}",
year = "2014",
month = "4",
day = "1",
doi = "10.1681/ASN.2013050557",
language = "English (US)",
volume = "25",
pages = "810--818",
journal = "Journal of the American Society of Nephrology",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "4",

}

TY - JOUR

T1 - Longitudinal changes in estimated and measured GFR in type 1 diabetes

AU - De Boer, Ian H.

AU - Sun, Wanjie

AU - Cleary, Patricia A.

AU - Lachin, John M.

AU - Molitch, Mark E.

AU - Zinman, Bernard

AU - Steffes, Michael W

PY - 2014/4/1

Y1 - 2014/4/1

N2 - Estimation of GFR from serum concentrations of creatinine and cystatin C has been refined using crosssectional data fromlarge numbers of people.However, the ability of the improved estimating equations to identify changes in GFR within individuals over time has not been rigorously evaluated, particularly within the normal range of GFR. In cross-sectional and longitudinal analyses of 1441 participants in the Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) study with type 1 diabetes, we compared GFR estimated from creatinine (eGFRCr), cystatin C (eGFRCys), or both (eGFRCr+Cys) with iothalamate GFR (iGFR), including changes in each over time. Mean (SD) iGFR was 122.7 (21.0)ml/min per 1.73m2. In cross-sectional analyses, eGFRCr+Cys estimated iGFRwith the highest correlation (r=0.48 versus 0.39-0.42), precision, and accuracy. In longitudinal analyses, change in eGFRCr+Cys best estimated change in iGFR; however, differences between estimates were small, and no estimate accurately classified change in iGFR.Over a median 23 years of follow-up,mean rate of change in eGFR was similar across estimates of eGFRCr, eGFRCys, and eGFRCr+Cys (21.37, 21.11, and 21.29 ml/min per 1.73 m2 per year, respectively). Associations of BP and hemoglobin A1c with change in eGFR were strongest for eGFRCys and eGFRCr+Cys. Together, these results suggest that the addition of cystatin C to creatinine to estimate GFRmay improve identification of the causes and consequences of GFR loss in type 1 diabetes, but may not meaningfully improve the tracking of GFR in clinical care.

AB - Estimation of GFR from serum concentrations of creatinine and cystatin C has been refined using crosssectional data fromlarge numbers of people.However, the ability of the improved estimating equations to identify changes in GFR within individuals over time has not been rigorously evaluated, particularly within the normal range of GFR. In cross-sectional and longitudinal analyses of 1441 participants in the Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) study with type 1 diabetes, we compared GFR estimated from creatinine (eGFRCr), cystatin C (eGFRCys), or both (eGFRCr+Cys) with iothalamate GFR (iGFR), including changes in each over time. Mean (SD) iGFR was 122.7 (21.0)ml/min per 1.73m2. In cross-sectional analyses, eGFRCr+Cys estimated iGFRwith the highest correlation (r=0.48 versus 0.39-0.42), precision, and accuracy. In longitudinal analyses, change in eGFRCr+Cys best estimated change in iGFR; however, differences between estimates were small, and no estimate accurately classified change in iGFR.Over a median 23 years of follow-up,mean rate of change in eGFR was similar across estimates of eGFRCr, eGFRCys, and eGFRCr+Cys (21.37, 21.11, and 21.29 ml/min per 1.73 m2 per year, respectively). Associations of BP and hemoglobin A1c with change in eGFR were strongest for eGFRCys and eGFRCr+Cys. Together, these results suggest that the addition of cystatin C to creatinine to estimate GFRmay improve identification of the causes and consequences of GFR loss in type 1 diabetes, but may not meaningfully improve the tracking of GFR in clinical care.

UR - http://www.scopus.com/inward/record.url?scp=84901504239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901504239&partnerID=8YFLogxK

U2 - 10.1681/ASN.2013050557

DO - 10.1681/ASN.2013050557

M3 - Article

VL - 25

SP - 810

EP - 818

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

SN - 1046-6673

IS - 4

ER -